Results
1 -
10 of
16
(Click
here to explore results)
- Identification and characterization of in vitro phase I and reactive metabolites of masitinib using a LC-MS/MS method: bioactivation pathway elucidation. Sawsan M. Amer, Adnan A. Kadi, Hany W. Darwish, Mohamed W. Attwa
, RSC Adv.
, 2017
, 7
, 4479
- Binding mechanism of inhibitors to SARS-CoV-2 main protease deciphered by multiple replica molecular dynamics simulations. Shanshan Liang, Xinguo Liu, Shaolong Zhang, Meng Li, Qinggang Zhang, Jianzhong Chen
, Phys. Chem. Chem. Phys.
, 2022
, 24
, 1743
- Application of post-genomic techniques in dog cancer research. F. Ceciliani, P. Roccabianca, C. Giudice, C. Lecchi
, Mol. BioSyst.
, 2016
, 12
, 2665
- Advances in research on 3C-like protease (3CLpro) inhibitors against SARS-CoV-2 since 2020. Roufen Chen, Yali Gao, Han Liu, He Li, Wenfa Chen, Junjie Ma
, RSC Med. Chem.
, 2023
, 14
, 9
- Validated liquid chromatography tandem mass spectrometry for simultaneous quantification of foretinib and lapatinib, and application to metabolic stability investigation. Mohammed M. Alanazi, Hamad M. Alkahtani, Abdulrahman A. Almehizia, Mohamed W. Attwa, Ahmed H. Bakheit, Hany W. Darwish
, RSC Adv.
, 2019
, 9
, 19325
- Development of a protease-resistant reporter to quantify BCR–ABL activity in intact cells. Angela Proctor, Imola G. Zigoneanu, Qunzhao Wang, Christopher E. Sims, David S. Lawrence, Nancy L. Allbritton
, Analyst
, 2016
, 141
, 6008
- The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib. Benjamin J. Deadman, Mark D. Hopkin, Ian R. Baxendale, Steven V. Ley
, Org. Biomol. Chem.
, 2013
, 11
, 1766
- On the origins of SARS-CoV-2 main protease inhibitors. Yves L. Janin
, RSC Med. Chem.
, 2024
, 15
, 81
- Small molecule therapeutics for neuroinflammation-mediated neurodegenerative disorders. Silke Miller, Maria-Jesus Blanco
, RSC Med. Chem.
, 2021
, 12
, 871
- In silico analysis of SOD1 aggregation inhibition modes of tertiary amine pyrazolone and pyrano coumarin ferulate as ALS drug candidates. Aziza Rahman, Bondeepa Saikia, Anupaul Baruah
, Phys. Chem. Chem. Phys.
, 2023
, 25
, 26833